Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.
van Schalkwijk DB, de Graaf AA, van Ommen B, van Bochove K, Rensen PC, Havekes LM, van de Pas NC, Hoefsloot HC, van der Greef J, Freidig AP. van Schalkwijk DB, et al. Among authors: van ommen b, van bochove k, van der greef j, van de pas nc. J Lipid Res. 2009 Dec;50(12):2398-411. doi: 10.1194/jlr.M800354-JLR200. Epub 2009 Jun 10. J Lipid Res. 2009. PMID: 19515990 Free PMC article.
Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation.
van Schalkwijk DB, Pasman WJ, Hendriks HF, Verheij ER, Rubingh CM, van Bochove K, Vaes WH, Adiels M, Freidig AP, de Graaf AA. van Schalkwijk DB, et al. Among authors: van bochove k. PLoS One. 2014 Jul 21;9(7):e100376. doi: 10.1371/journal.pone.0100376. eCollection 2014. PLoS One. 2014. PMID: 25049048 Free PMC article. Clinical Trial.
Developing computational model-based diagnostics to analyse clinical chemistry data.
van Schalkwijk DB, van Bochove K, van Ommen B, Freidig AP, van Someren EP, van der Greef J, de Graaf AA. van Schalkwijk DB, et al. Among authors: van ommen b, van someren ep, van bochove k, van der greef j. Brief Bioinform. 2010 Jul;11(4):403-16. doi: 10.1093/bib/bbp071. Epub 2010 Jan 7. Brief Bioinform. 2010. PMID: 20056728
Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.
Zhang C, Bijlard J, Staiger C, Scollen S, van Enckevort D, Hoogstrate Y, Senf A, Hiltemann S, Repo S, Pipping W, Bierkens M, Payralbe S, Stringer B, Heringa J, Stubbs A, Bonino Da Silva Santos LO, Belien J, Weistra W, Azevedo R, van Bochove K, Meijer G, Boiten JW, Rambla J, Fijneman R, Spalding JD, Abeln S. Zhang C, et al. Among authors: van enckevort d, van bochove k. F1000Res. 2017 Aug 16;6:ELIXIR-1488. doi: 10.12688/f1000research.12168.1. eCollection 2017. F1000Res. 2017. PMID: 29123641 Free PMC article.
Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative.
Bruinsma SM, Nieboer D, Roobol MJ, Bangma CH, Verbeek JFM, Gnanapragasam V, Van Hemelrijck M, Frydenberg M, Lee LS, Valdagni R, Logothetis C, Steyerberg EW; the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Bruinsma SM, et al. J Urol. 2021 Jul;206(1):62-68. doi: 10.1097/JU.0000000000001700. Epub 2021 Feb 22. J Urol. 2021. PMID: 33617330
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patients.
Crump RT, Remmers S, Van Hemelrijck M, Helleman J, Nieboer D, Roobol MJ, Venderbos LDF; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Crump RT, et al. Transl Androl Urol. 2021 Jun;10(6):2719-2727. doi: 10.21037/tau-20-1255. Transl Androl Urol. 2021. PMID: 34295757 Free PMC article.
A first step towards a global nomogram to predict disease progression for men on active surveillance.
Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, Nieboer D, Bangma C, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam V, Kattan MW; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Van Hemelrijck M, et al. Transl Androl Urol. 2021 Mar;10(3):1102-1109. doi: 10.21037/tau-20-1082. Transl Androl Urol. 2021. PMID: 33850745 Free PMC article.
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer.
Beyer K, MacLennan SJ, Moris L, Lardas M, Mastris K, Hooker G, Greene R, Briers E, Omar MI, Healey J, Tripathee S, Gandaglia G, Venderbos LDF, Smith EJ, Bjorkqvist J, Asiimwe A, Huber J, Roobol MJ, Zong J, Bjartell A, N'Dow J, Briganti A, MacLennan S, Van Hemelrijck M; PIONEER Consortium; EAU; LU; UNISR; Erasmus; UKE; TAU; KCL; EORTC; TTOP; ICHOM; ECPC; ASSOC EISBM; ICL; Hyve; EAPM; PM; WI; UoA; TUD; Fraunhofer; UGOT; Radboud; IHE; Bayer AG; SANOFI; ASTELLAS; SAS; Janssen; IQVIA; eGF-eCancer; AstraZeneca; HelmHoltz. Beyer K, et al. Eur Urol Focus. 2021 Sep;7(5):943-946. doi: 10.1016/j.euf.2021.09.008. Epub 2021 Oct 1. Eur Urol Focus. 2021. PMID: 34602368 Free article.
37 results